EU Court Rules Against Von der Leyen in Pfizer Vaccine Deal Scandal

Ursula von der Leyen Faces Court Ruling in Pfizer Vaccine Deal Controversy A European court has issued a non-binding ruling against European Commission President Ursula von der Leyen concerning the EU's vaccine procurement deal with Pfizer. The ruling stems from a data request by The New York Times, which was denied by the Commission. The court's decision mandates the release of communications between von der Leyen and Pfizer's CEO. This case has drawn significant attention from mainstream European media outlets, highlighting the importance of transparency in public procurement. While the ruling is not yet legally binding, it puts pressure on von der Leyen to disclose the previously undisclosed communications. The details of the deal, including its financial aspects, remain largely opaque, raising questions about potential conflicts of interest and the overall management of the vaccine rollout. This case underscores the ongoing debate about transparency and accountability in the EU's handling of the pandemic.